Pharming H1 EPS $(0.02) Down From $0.03 YoY, Sales $97.40M Up From $96.80M YoY
Portfolio Pulse from Benzinga Newsdesk
Pharming (NASDAQ:PHAR) reported a decrease in earnings per share (EPS) from $0.03 to $(0.02) YoY, a 166.67% decrease. However, the company's sales increased slightly by 0.62% to $97.40 million from $96.80 million YoY.
August 04, 2023 | 12:36 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Pharming's earnings per share decreased significantly, while sales saw a slight increase.
The significant decrease in earnings per share indicates a decline in profitability, which could negatively impact the stock price. However, the slight increase in sales could offset this to some extent.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100